Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17213612 | 0.91 | MTNR1A (0.45) | MTNR1AMTNR1BPOLBAPEX1HTT | |
| SCHEMBL13017961 | 0.89 | MTNR1A (0.43) | MTNR1AMTNR1BPOLBAPEX1HTT | |
| SCHEMBL2721760 | 0.89 | MTNR1A (0.43) | MTNR1AMTNR1B | |
| SCHEMBL17034329 | 0.88 | MAPT (0.43) | MTNR1AMTNR1BPOLBAPEX1HTT | |
| SCHEMBL13017917 | 0.88 | MTNR1A (0.41) | MTNR1AMTNR1BPOLBAPEX1HTT | |
| SCHEMBL2721446 | 0.88 | MTNR1A (0.43) | MTNR1AMTNR1BPOLBAPEX1HTT | |
| SCHEMBL13017925 | 0.87 | AR (0.47) | POLBHTTTDP1 | |
| SCHEMBL2719066 | 0.87 | MTNR1A (0.41) | MTNR1AMTNR1B | |
| SCHEMBL2719349 | 0.86 | MTNR1A (0.42) | MTNR1AMTNR1BPOLBAPEX1HTT | |
| SCHEMBL17034212 | 0.86 | MAPT (0.43) | MTNR1AMTNR1BPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858159-B2 | Photocurable composition for sealant, liquid crystal sealant, and liquid crystal panel | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-7858159-B2 | Photocurable composition for sealant, liquid crystal sealant, and liquid crystal panel | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20090131550-A1 | PHOTOCURABLE COMPOSITION FOR SEALANT, LIQUID CRYSTAL SEALANT, AND LIQUID CRYSTAL PANEL | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2009-05-21 | — | — | US | disclosed |
| US-20090131550-A1 | PHOTOCURABLE COMPOSITION FOR SEALANT, LIQUID CRYSTAL SEALANT, AND LIQUID CRYSTAL PANEL | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131550-A1 | PHOTOCURABLE COMPOSITION FOR SEALANT, LIQUID CRYSTAL SEALANT, AND LIQUID CRYSTAL PANEL | TRPA1, ANXA1, ANXA11 | MTNR1A 1198/4885MTNR1B 2088/4885POLB 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.